Prescription drug · ANDA
Tazicef (Ceftazidime) NDC 0409-5082
Ceftazidime 1 g/1 · Injection, Powder, For solution · Intramuscular, Intravenous · Hospira, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0409-5082-10 | 00409508210 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11)Marketed from May 5, 2026 | |
| 0409-5082-16 | 00409508216 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11)Marketed from Nov 2, 2005 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tazicef
- Generic name (nonproprietary)
- ceftazidime
- Active ingredients
- Ceftazidime — 1 g/1
- Dosage form
- Injection, Powder, For solution
- Route
- Intramuscular, Intravenous
- Labeler
- Hospira, Inc.NDC labeler code 0409
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 062662
- Marketing start
- Listing expires
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 0409-5082_ab9c6f3a-f684-4cc3-b870-1a06a748a1a2SPL ID ab9c6f3a-f684-4cc3-b870-1a06a748a1a2SPL set ID 40d48c5d-650e-461b-a67b-7e65772d1b92RxCUI 1659283, 1659287, 1659292, 1659294UNII 9M416Z9QNR
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400409508210followed by a unit qualifier and the quantityPackage 00409-5082-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Tazicef (ceftazidime for injection) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: 1. Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Haemophilus influenzae , including ampicillin-resistant strains; Klebsiella spp.; Enterobacter spp.; Proteus mirabilis ; Escherichia coli ; Serratia spp.; Citrobacter spp.; Streptococcus pneumoniae ; and Staphylococcus aureus (methicillin-susceptible strains). 2. Skin and Skin-Structure Infections caused by Pseudomonas aeruginosa ; Klebsiella spp.; Escherichia coli ; Proteus…
Excerpt only. Read the full label for complete information.
About NDC 0409-5082
- What is NDC 0409-5082?
- 0409-5082 is the product NDC for Tazicef (ceftazidime), Ceftazidime 1 g/1 injection, powder, for solution, listed with the FDA by Hospira, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tazicef (Ceftazidime).
- What is the active ingredient?
- Ceftazidime.
- Who is the labeler?
- Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tazicef?
- 2 other product NDCs are listed under this name. See all Tazicef NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tazicef products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tazicefceftazidime | Ceftazidime 6 g/1 | Injection, Powder, For solutionIntravenous | Hospira, Inc. | 0409-5086 | 00409-5086-11 |
| Tazicefceftazidime | Ceftazidime 2 g/1 | Injection, Powder, For solutionIntravenous | Hospira, Inc. | 0409-5084 | 00409-5084-11 |
Other NDCs under ANDA 062662
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tazicefceftazidime | Ceftazidime 2 g/1 | Injection, Powder, For solutionIntravenous | Hospira, Inc. | 0409-5084 |
| Tazicefceftazidime | Ceftazidime 6 g/1 | Injection, Powder, For solutionIntravenous | Hospira, Inc. | 0409-5086 |